These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2456835)

  • 1. Dendrotoxin and 4-aminopyridine potentiate neurohypophysial hormone secretion during low frequency electrical stimulation.
    Bondy CA; Russell JT
    Brain Res; 1988 Jun; 453(1-2):397-400. PubMed ID: 2456835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of potassium channel blockers on neurohypophysial release of oxytocin and vasopressin. Evidence for frequency-dependent interaction with the endogenous opioid inhibition of oxytocin release.
    Racké K; Altes U; Baur AM; Hobbach HP; Jost D; Schäfer J; Wammack R
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Nov; 338(5):560-6. PubMed ID: 2854213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetraethylammonium ions and 4-aminopyridine prevent opioid inhibition of neurohypophysial oxytocin release.
    Racké K; Altes U; Baur AM; Jost D; Schäfer J
    Brain Res; 1987 Dec; 436(2):371-3. PubMed ID: 2829994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of stimulus frequency and potassium channel blockade on the secretion of vasopressin and oxytocin from the neurohypophysis.
    Bondy CA; Gainer H; Russell JT
    Neuroendocrinology; 1987 Sep; 46(3):258-67. PubMed ID: 2443864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activators of protein kinase C potentiate electrically stimulated hormone secretion from the rat's isolated neurohypophysis.
    Bondy CA; Gainer H
    Neurosci Lett; 1988 Jun; 89(1):97-101. PubMed ID: 3165164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous opioid inhibition of the release of oxytocin from the isolated rat neurohypophysis during high-frequency stimulation of the pituitary stalk.
    Wammack R; Racké K
    Neurosci Lett; 1988 Sep; 92(1):114-8. PubMed ID: 3185974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency-dependent effects of activation and inhibition of protein kinase C on neurohypophysial release of oxytocin and vasopressin.
    Racké K; Burns F; Haas B; Niebauer J; Pitzius E
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):617-24. PubMed ID: 2770888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine tolerance and inhibition of oxytocin secretion by kappa-opioids acting on the rat neurohypophysis.
    Russell JA; Coombes JE; Leng G; Bicknell RJ
    J Physiol; 1993 Sep; 469():365-86. PubMed ID: 8271202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynorphin A inhibits and naloxone increases the electrically stimulated release of oxytocin but not vasopressin from the terminals of the neural lobe.
    Bondy CA; Gainer H; Russell JT
    Endocrinology; 1988 Apr; 122(4):1321-7. PubMed ID: 2894296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular calcium and hormone release from nerve endings of the neurohypophysis in the presence of opioid agonists and antagonists.
    Dayanithi G; Stuenkel EL; Nordmann JJ
    Exp Brain Res; 1992; 90(3):539-45. PubMed ID: 1358668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydropyridine ligands influence the evoked release of oxytocin and vasopressin dependent on stimulation conditions.
    Jørgensen A; Fjalland B; Christensen JD; Treiman M
    Eur J Pharmacol; 1994 Jul; 259(2):157-63. PubMed ID: 7957609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do opioid peptides modulate, at the level of the nerve endings, the release of neurohypophysial hormones?
    Nordmann JJ; Dayanithi G; Cazalis M
    Exp Brain Res; 1986; 61(3):560-6. PubMed ID: 3514253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kappa-opioid receptor agonists differentially affect the release of neurohypophysial hormones.
    Fjalland B; Christensen JD
    Pharmacol Toxicol; 1990 Mar; 66(3):176-8. PubMed ID: 2159141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous opiates regulate oxytocin but not vasopressin secretion from the neurohypophysis.
    Bicknell RJ; Leng G
    Nature; 1982 Jul; 298(5870):161-2. PubMed ID: 7088170
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of naloxone on vasopressin release from rat neurohypophysis incubated in vitro.
    Knepel W; Meyer DK
    J Physiol; 1983 Aug; 341():507-15. PubMed ID: 6620188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid-noradrenergic interactions in the neurohypophysis. I. Differential opioid receptor regulation of oxytocin, vasopressin, and noradrenaline release.
    Zhao BG; Chapman C; Bicknell RJ
    Neuroendocrinology; 1988 Jul; 48(1):16-24. PubMed ID: 2845291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relaxin affects the release of oxytocin and vasopressin from the neurohypophysis.
    Dayanithi G; Cazalis M; Nordmann JJ
    Nature; 1987 Feb 26-Mar 4; 325(6107):813-6. PubMed ID: 2434861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of interleukin-1 beta on the secretion of oxytocin and vasopressin from the isolated rat neurohypophysis.
    Christensen JD; Hansen EW; Fjalland B
    Pharmacol Toxicol; 1990 Jul; 67(1):81-3. PubMed ID: 2395821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of raised extracellular potassium on the excitability of, and hormone release from, the isolated rat neurohypophysis.
    Leng G; Shibuki K; Way SA
    J Physiol; 1988 May; 399():591-605. PubMed ID: 3404469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid inhibition of secretion from oxytocin and vasopressin nerve terminals following selective depletion of neurohypophysial catecholamines.
    Bicknell RJ; Zhao BG; Chapman C; Heavens RP; Sirinathsinghji DJ
    Neurosci Lett; 1988 Nov; 93(2-3):281-6. PubMed ID: 3241653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.